Mechanism of the Decrease in Catalytic Activity of Human Cytochrome P450 2C9 Polymorphic Variants Investigated by Computational Analysis

被引:40
|
作者
Sano, Eri [1 ]
Li, Weihua [1 ]
Yuki, Hitomi [1 ]
Liu, Xinli [1 ]
Furihata, Tomomi [2 ]
Kobayashi, Kaoru [2 ]
Chiba, Kan [2 ]
Neya, Saburo [1 ]
Hoshino, Tyuji [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Phys Chem, Chiba 2638522, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Chiba 2608675, Japan
基金
日本学术振兴会;
关键词
cytochrome P450; polymorphism; enzymatic activity; molecular dynamics; docking simulation; MOLECULAR-DYNAMICS SIMULATION; FORCE-FIELD PARAMETERS; MONOOXYGENATION MECHANISM; POSSIBLE PATHWAY(S); FLEXIBLE DOCKING; HIV-1; PROTEASES; BINDING MODES; IN-VITRO; SITE; CYP2C9;
D O I
10.1002/jcc.21568
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cytochrome P450 (CYP) is deeply involved in the metabolism of chemicals including pharmaceuticals. Therefore, polymorphisms of this enzyme have been widely studied to avoid unfavorable side effects of drugs in chemotherapy. In this work, we performed computational analysis of the mechanism of the decrease in enzymatic activity for three typical polymorphisms in CYP 2C9 species: *2, *3, and *5. Based on the equilibrated structure obtained by molecular dynamics simulation, the volume of the binding pocket and the fluctuation of amino residues responsible for substrate holding were compared between the wild type and the three variants. Further docking simulation was carried out to evaluate the appropriateness of the binding pocket to accommodate substrate chemicals. Every polymorphic variant was suggested to be inferior to the wild type in enzymatic ability from the structural viewpoint. F-G helices were obviously displaced outward in CYP2C9*2. Expansion of the binding pocket, especially the space near F' helix, was remarkable in CYP2C9*3. Disappearance of the hydrogen bond between K helix and beta 4 loop was observed in CYP2C9*5. The reduction of catalytic activity of those variants can be explained from the deformation of the binding pocket and the consequent change in binding mode of substrate chemicals. The computational approach is effective for predicting the enzymatic activity of polymorphic variants of CYP. This prediction will be helpful for advanced drug design because calculations forecast unexpected change in drug efficacy for individuals. (C) 2010 Wiley Periodicals, Inc. J Comput Chem 31: 2746-2758, 2010
引用
收藏
页码:2746 / 2758
页数:13
相关论文
共 50 条
  • [21] Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population
    Zand, Negin
    Tajik, Nader
    Moghaddam, Alireza Salek
    Milanian, Iraj
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (1-2) : 102 - 105
  • [22] Multiple, Ligand-dependent Routes from the Active Site of Cytochrome P450 2C9
    Cojocaru, Vlad
    Winn, Peter J.
    Wade, Rebecca C.
    CURRENT DRUG METABOLISM, 2012, 13 (02) : 143 - 154
  • [23] In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9
    Iwasaki, Kazuhide
    Kitsugi, Yusuke
    Ikeda, Kanami
    Yoshikawa, Takahiro
    Hosaka, Shinya
    Uehara, Shotaro
    Uno, Yasuhiro
    Utoh, Masahiro
    Yamazaki, Hiroshi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (06) : 379 - 383
  • [24] Evaluation of cytochrome P450 2C9 activity in normal, healthy, adult Western Indian population by both phenotyping and genotyping
    Swar, Balkrishna D.
    Bendkhale, Shital R.
    Rupawala, Abbas
    Sridharan, Kannan
    Gogtay, Nithya J.
    Thatte, Urmila M.
    Kshirsagar, Nilima A.
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (03) : 248 - 251
  • [25] Mechanism-Based Inactivation of Cytochrome P450 2C9 by Tienilic Acid and (±)-Suprofen: A Comparison of Kinetics and Probe Substrate Selection
    Hutzler, J. Matthew
    Balogh, Larissa M.
    Zientek, Michael
    Kumar, Vikas
    Tracy, Timothy S.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 59 - 65
  • [26] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [27] Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region
    Varshney, Ekta
    Saha, Nilanjan
    Tandon, Monika
    Shrivastava, Vikesh
    Ali, Shakir
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2013, 38 (04) : 275 - 282
  • [28] Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
    Lim, Sharoen Yu Ming
    Al Bishtawi, Basel
    Lim, Willone
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (03) : 221 - 240
  • [29] Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
    Jiang, Rongrong
    Yamaori, Satoshi
    Okamoto, Yasuka
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (04) : 332 - 338
  • [30] Differential Oxidation of Two Thiophene-Containing Regioisomers to Reactive Metabolites by Cytochrome P450 2C9
    Rademacher, Peter M.
    Woods, Caleb M.
    Huang, Qingbiao
    Szklarz, Grazyna D.
    Nelson, Sidney D.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (04) : 895 - 903